G+T has advised Australian digital health pioneer, Eucalyptus, on its USD1.15 billion acquisition by NYSE-listed Hims & Hers Health, Inc, under a securities sale deed pursuant to which Hims & Hers Health, Inc will acquire 100% of the equity of Eucalyptus. The purchaser has the right to elect to pay a significant portion of the consideration in its listed shares rather than cash.
The transaction is subject to regulatory approvals and is expected to close in mid-2026. Upon completion, Eucalyptus will lead the international business of Hims & Hers.
The G+T team was led by partners Adam D’Andreti and Xavier Keary, supported by Catherine Wei, Henry Simpson and Omar Harduwar. Cooley acted as US counsel to Eucalyptus.
